Ilaris (canakinumab) is a prescription drug that’s used to treat certain conditions such as Still disease. Ilaris comes as a liquid solution that a healthcare professional will give as an injection ...

The prescribed dosage for Ilaris (canakinumab) may depend on your individual treatment plan. Factors like your medical history and body weight may affect your dosage of Ilaris. Ilaris (canakinumab) is ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Novartis’ Ilaris injection for the treatment of active and adult-onset Still’s disease, ...

Jul 28, 2009 -- Swiss pharmaceutical group Novartis has reported that the EU's Committee on Human Medicinal Products has issued a positive opinion recommending the approval of Ilaris for ...

ZURICH, May 10 (Reuters) - Novartis said on Friday the U.S. Food and Drug Administration (FDA) had approved its drug Ilaris to treat a serious form of childhood arthritis. Ilaris inhibits ...

Ilaris (canakinumab) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to treat certain periodic fever conditions and certain types of Still’s disease.

Stocks limped to the end of the week on Friday, the dollar was set for its worst week in a month while gold flirted with a record peak as investors feared U.S. President Donald Trump's sweeping ...